GENE THERAPY WITH K+ CHANNELS PRESERVES ERECTILE CAPACITY IN THE FACE OF DIMINISHED NEURONAL INNERVATION FOLLOWING 12-16 WEEKS OF EXPERIMENTAL DIABETES IN RATS